Web Results

caselaw.findlaw.com/us-supreme-court/09-152.html

United States Supreme Court. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09-152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely ...

www.cohenmilstein.com/case-study/usa-ex-rel-lauren-kieff-et-al-v-wyeth

In February 2016, Pfizer subsidiary Wyeth agreed in principle to pay $784.6 million to the U.S. Government, 37 states and the District of Columbia to resolve False Claims Act charges filed by whistleblower Lauren Kieff that Wyeth overcharged Medicaid programs by underpaying drug rebates for the acid suppression drugs ...

www.law.uh.edu/healthlaw/perspectives/Food/990825Liability.html

The opinion contains an extensive discussion of direct-to-consumer advertising, the "learned intermediary" doctrine, and the changing roles of consumers, physicians, drug manufacturers, and managed care organizations in the current health care marketplace. In Perez v. Wyeth Laboratories Inc., A-16 Sept. Term 1998 ...

citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.781.9151&rep=rep1&type=pdf

May 13, 2011 ... Citation: Rudick RA, Rani MRS, Xu Y, Lee J-C, Na J, et al. (2011) Excessive ... Honoraria: Biogen, Teva Travel expenses: Biogen, Genzyme, Millenium, Wyeth, Pfizer. This does not .... Comparison of baseline characteristics between patients with a good vs poor response to IFNb treatment.*. Characteristic.

www.croh-online.com/article/S1040-8428(03)00068-4/fulltext

Significant progress has been made in understanding the biology of urothelial and kidney cancers. Approaches to advanced urothelial cancer include dose intensification, reducing toxicity in unfit or elderly patients, doublet and triplet combination chemotherapy and sequential regimens. Promising new chemotherapeutic ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4003837

Apr 10, 2014 ... Background. The MC1R gene implicated in melanogenesis and skin pigmentation is highly polymorphic. Several alleles are associated with red hair and fair skin phenotypes and contribute to melanoma risk. Objective. This work aims to assess the effect of different classes of MC1R variants, notably rare ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4676704

Dec 11, 2015 ... The melanocortin 1 receptor gene (MC1R) expressed in melanocytes is a major determinant of skin pigmentation. It encodes a Gs protein-coupled receptor activated by α-melanocyte stimulating hormone (αMSH). Human MC1R has an inefficient poly(A) site allowing intergenic splicing with its downstream ...

digitalcommons.wustl.edu/cgi/viewcontent.cgi?article=5038&context=open_access_pubs

Jun 23, 2015 ... Recommended Citation. Bowcock, Anne; Cornelius, Lynn; Council, Martha Laurin; and et al, ,"MC1R gene variants and non-melanoma skin cancer: A pooled- analysis from the M-SKIP project." British Journal of Cancer.113,2. 354- 363. (2015). http://digitalcommons.wustl.edu/open_access_pubs/4034 ...

www.omim.org/entry/155555

Mountjoy et al. (1992) cloned the murine and human MSH receptors and a human ACTH receptor (202200). These receptors were said to define a subfamily of receptors coupled to G proteins that may include the cannabinoid receptor ( 114610). The human MSH receptor was 76% identical to the amino acid sequence of ...